Safety Data on Hepatitis B Vaccine for Newborns ‘Sadly Lacking

hepatitis b vaccine newborns safety feature

By  Dr. Joseph Mercola

The U.S. Food and Drug Administration approved Recombivax HB, the hepatitis B vaccine for newborns, based on clinical trials performed on only 147 infants and children who were monitored for just five days.

Story at a glance:

The safety data on Recombivax HB, the hepatitis B vaccine for newborns, are sadly lacking, as the U.S. Food and Drug Administration (FDA) approved the shot based on clinical trials performed on only 147 infants and children and followed for only five days.There are four hepatitis B vaccines, two of which are approved for infants; the second approved for infants is Engerix-B, and clinical safety data show infants and children were followed for only four days in these trials.Most infants are not at high risk for hepatitis B. It makes better financial and health sense to test mothers before birth and vaccinate only those infants born to mothers with an active or chronic hepatitis B infection, putting off vaccination in other infants until they are older.The current childhood vaccination schedule includes 19 potential doses of vaccines and one mRNA experimental injection by the time an infant is 6 months old. Many of these contain aluminum, which raises a child’s risk of persistent asthma in childhood.

[…]

One thing that is certain is we all want our children to be healthy and safe from unnecessary harm.

However, as lead attorney for Informed Consent Action Network (ICAN), Aaron Siri explains, just one example of the negligence in regulations is the sadly lacking safety data on the hepatitis B vaccine for newborns.

Newborns given hepatitis B vax without proper safety data

Before a newborn leaves the hospital, they’re given one vaccine for hepatitis B, even though the safety data for it is scant, if that.

According to Siri, the clinical trials designed to protect newborns included only 434 doses of Recombivax HB given to 147 healthy infants and children up to 10 years of age, and these children were monitored for only five days after each dose.

[..]

Siri also notes, there is no indication there was a control group in the studies.

[[…]

On behalf of ICAN, Siri’s firm has filed a petition with the FDA requesting either a proper clinical trial to ascertain side effects and efficacy or withdrawing the licensure from Merck.

By law, the FDA has six months to respond to such a request which, according to Siri, has expired. Having not received a formal response from the FDA, the plan is to sue the FDA in federal court over this issue.

Most infants are not at high risk for hepatitis B

According to the Centers for Disease Control and Prevention (CDC), the leading means of transmission include spread when infected blood, semen or other bodily fluids are transferred to an uninfected person.

This happens through shared needles or other drug equipment, sexual contact, or from mother to baby at birth.

[…]

Childhood shot schedule: 20 shots before 6 months

In the precious early months of life, when an infant’s brain and immune system are continuing to grow, most receive up to 20 injections of vaccines that parents are told will protect their child.

Beyond the hepatitis B newborn shot, at 2 months old they get six vaccine doses including a second hepatitis B, diphtheria, tetanus, pertussis, Haemophilus influenzae type b, pneumococcal conjugate and inactivated poliovirus.

Some are repeated at 4 months and 6 months, when they also receive their first flu and COVID-19 shot. All told, there are potentially 19 doses of vaccine and one dose of an experimental mRNA injection an infant could receive by 6 months of age.

[…]

Aluminum in the hepatitis vaccine exacerbates asthma

According to the CDC, one cost of following the childhood vaccination schedule is persistent asthma linked to aluminum exposure. Aluminum is the most common vaccine adjuvant, and the hepatitis B vaccine is one that contains it.

Despite its neurotoxicity, manufacturers add aluminum to vaccines to create an enhanced inflammatory response that theoretically generates higher protective antibodies.

However, an increasing number of parents say that repeated exposure to vaccines with aluminum may be harming their children. Indeed, previous animal studies demonstrated that aluminum increases the risk of allergy by inducing a T helper 2 cell-biased immune response.

In other words, the aluminum causes the T cells to be overactivated, which then exacerbates allergic responses.

[…]

In a January study with 326,991 children born from 2008 to 2014, they set out to assess “the association between cumulative aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months.”

They found there was a 1.26- and 1.19-times higher risk of persistent asthma for each additional milligram of vaccine-related aluminum exposure. The observational study stopped short of saying that it proves a link between aluminum-containing vaccines and asthma.

The CDC also stated that it has no intention of altering its vaccine recommendations based on this study alone.

However, the researchers pointed out that rates of asthma in U.S. children steadily increased in the 1980s and 1990s, then remained steady since 2001.

The 2001 date is significant, as most aluminum-containing vaccines were added to the childhood vaccine schedule before 2001.

[…]

It’s time for rational discussions on vaccine safety

Unofficial surveys have suggested that highly vaccinated children may have more chronic health problems than unvaccinated children, and that unvaccinated children have a far lower incidence rate of autism.

[…]

COVID jab added to secure indemnification

In yet another display of sacrificing children for Big Pharma and profits, the U.S. became the first country in the world to grant emergency use authorization for Pfizer’s and Moderna’s COVID-19 jabs to toddlers and children as young as 6 months.

[…]

By adding the shots to the vaccine schedule, it paves the way for U.S. schools to require them for attendance.

[…]

Pfizer and Moderna, the shots’ makers, will also be granted permanent legal indemnity, which otherwise would have disappeared once COVID-19 shots were no longer protected under emergency use authorization.

[…]

Via https://childrenshealthdefense.org/defender/hepatitis-b-vaccine-newborns-safety-data-cola/?eType=EmailBlastContent&eId=81409887-19d1-491d-a3ef-3208f24499d6

 •  0 comments  •  flag
Share on Twitter
Published on March 02, 2023 14:23
No comments have been added yet.


The Most Revolutionary Act

Stuart Jeanne Bramhall
Uncensored updates on world affairs, economics, the environment and medicine.
Follow Stuart Jeanne Bramhall's blog with rss.